1. Home
  2. SBSI vs KALV Comparison

SBSI vs KALV Comparison

Compare SBSI & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southside Bancshares Inc.

SBSI

Southside Bancshares Inc.

HOLD

Current Price

$33.15

Market Cap

974.1M

Sector

Finance

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$26.97

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SBSI
KALV
Founded
1960
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
974.1M
1.0B
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
SBSI
KALV
Price
$33.15
$26.97
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$35.33
$32.60
AVG Volume (30 Days)
58.2K
2.8M
Earning Date
04-30-2026
07-09-2026
Dividend Yield
4.42%
N/A
EPS Growth
N/A
N/A
EPS
0.78
N/A
Revenue
N/A
$50,000,000.00
Revenue This Year
$28.87
$185.42
Revenue Next Year
$5.82
$59.23
P/E Ratio
$42.22
N/A
Revenue Growth
N/A
495.66
52 Week Low
$26.32
$9.83
52 Week High
$34.53
$26.98

Technical Indicators

Market Signals
Indicator
SBSI
KALV
Relative Strength Index (RSI) 54.90 75.23
Support Level $31.73 $14.22
Resistance Level $34.22 N/A
Average True Range (ATR) 0.72 0.05
MACD 0.01 -0.26
Stochastic Oscillator 85.77 87.04

Price Performance

Historical Comparison
SBSI
KALV

About SBSI Southside Bancshares Inc.

Southside Bancshares Inc is a bank holding company. Through its subsidiary, it operates as a financial institution offering various financial services to individuals, businesses, municipal entities, and nonprofit organizations. These services include consumer and commercial loans, deposit accounts, wealth management and trust services, brokerage services, and safe deposit services. The company's primary market areas are East Texas, Southeast Texas, and the greater Dallas-Fort Worth, Austin, and Houston, Texas.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: